|本期目录/Table of Contents|

[1]李志强,陈 凯,杨拴盈.经鼻高流量氧疗联合糖皮质激素治疗重症社区获得性肺炎患者的临床分析[J].中华肺部疾病杂志,2021,(04):514-517.[doi:10.3877/cma.j.issn.1674-6902.2021.04.031]
点击复制

经鼻高流量氧疗联合糖皮质激素治疗重症社区获得性肺炎患者的临床分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2021年04期
页码:
514-517
栏目:
短篇论著
出版日期:
2021-08-20

文章信息/Info

Title:
-
作者:
李志强1; 2; 陈 凯2; 杨拴盈1
710004 西安,西安交通大学第二附属医院呼吸与危重症医学科1 721008 宝鸡,宝鸡市中心医院呼吸与危重症医学科2
Author(s):
-
关键词:
重症社区获得性肺炎;  经鼻高流量氧疗;  糖皮质激素
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2021.04.031
摘要:
-
Abstract:
-

参考文献/References:

1 PereiraJM, LaszczyńskaO, AzevedoA, et al. Early prediction of treatment failure in severe community-acquired pneumonia: the PRoFeSs score?[J]. J Crit Care, 2019, 53: 38-45.
2 GüellE, Martín-FernandezM, De la TorreMC, et al. Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock?[J]. J ClinMed, 2019, 8(5).pii:E754.
3 Mauri T, Turrini C, Eronia N, et al. Physiologic Effects of High-flow nasal cannula in acute hypoxemic Respiratory failure[J]. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
4 李正东, 詹庆元. 经鼻高流量氧疗[J]. 中国临床新医学, 2019, 12(1): 5-9.
5 Dysart K, Miller TL, Wolfson MR, et al. Research in high flow therapy: mechanisms of action[J]. Respir Med, 2009, 103(10): 1400-11405.
6 Hasani A, Chapman TH, McCool D, et al. Domiciliaryhumidification improves lung mucociliary clearance inpatients with bronchiectasis[J]. Chron Respir Dis, 2008, 5(2): 81-86.
7 黄琳娜, 李正东, 夏金根, 等. 经鼻高流量氧疗在急性呼吸衰竭治疗中的应用[J].中华结核和呼吸杂志, 2019, 42(1): 41-44.
8 中华医学会呼吸病学分会呼吸危重症医学学组, 中国医师协会呼吸医师分会危重症医学工作委员会. 成人经鼻高流量湿化氧疗临床规范应用专家共识[J]. 中华结核和呼吸杂志, 2019, 42(2): 83-91.
9 Bin Cao, Hainv Gao, Boping Zhou, et al. Adjuvant corticosteroid treatment in adults with influenza A(H7N9)viral pneumonia[J]. Crit Care Med, 2016, 44(6): e318-e328.
10 De Pascale G, Bello G, Antonelli M. Steroids in severe pneumonia: a literature review[J]. Minerva Anestesiol, 2011, 77(9): 902-910.
11 Schuliga Michael, Vancurova Ivana. NF-κappa B signaling in chronic inflammatory airway disease[J]. Biomolecules, 2015, 5(3): 1266-1283.
12 Long B, Koyfman A. Controversies in corticosteroid use for sepsis[J]. J Emerg Med, 2017, 53(5): 653-661.
13 Avrom Caplan, Nicole Fett, Misha Rosenbach, et al. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations[J]. J Am Acad Dermatol, 2017, 76(2): 191-198.
14 Oray M, Abu Samra K, Ebrahimiadib N, et al. Long-term side effects of glucocorticoid[J]. Expert Opin Drug Saf, 2016, 15(4): 457-465.
15 Chatterjee Arjun B. Review: Corticosteroids reduce mechanical ventilation and ARDS in inpatients with community-acquired pneumonia[J]. Ann Int Med, 2015, 163(12): JC2.
16 Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia[J]. Influenza Other Respir Viruses, 2017, 11(4): 345-354.
17 Chen R, Tang X, Tan Y, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience[J]. Chest, 2006, 129(6): 1441-1452.
18 Wan YD, Sun TW, Liu ZQ, et al. Efficacy and safety of corticosteroids for community-acquired pneumonia:A systematic review and meta-analysis[J]. Chest, 2016, 149(1): 209-219.
19 Salluh Jorge IF, Soares Márcio, Coelho Luis M, et al. Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study[J]. J Crit Care, 2011, 26(2): 193-200.
20 Adcock IM, Mumby S. Glucocorticoids[J]. Handb Exp Pharmacol, 2017, 237: 171-196.
21 Vandewalle J, Luypaert A, De Bosscher K, et al. Therapeutic mechanisms of glucocorticoids[J]. Trends Endocrinol Metab, 2018, 29(1): 42-54.

备注/Memo

备注/Memo:
基金项目: 陕西省卫生健康科研基金(2018SF-218)
通信作者: 杨拴盈, Email: yangshuanying@xjtu.edu.cn
更新日期/Last Update: 2021-08-20